Wealth Enhancement Trust Services, Inc. Crispr Therapeutics Ag Transaction History
Wealth Enhancement Trust Services, Inc.
- $792 Billion
- Q4 2025
A detailed history of Wealth Enhancement Trust Services, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Wealth Enhancement Trust Services, Inc. holds 38,753 shares of CRSP stock, worth $2.14 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
38,753Holding current value
$2.14 Million% of portfolio
0.26%Shares
1 transactions
Others Institutions Holding CRSP
# of Institutions
546Shares Held
67.4MCall Options Held
3.5MPut Options Held
3.08M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.79MShares$541 Million4.45% of portfolio
-
Capital International Investors Los Angeles, CA5.65MShares$313 Million0.06% of portfolio
-
Orbis Allan Gray LTD Hamilton, D04.98MShares$276 Million1.8% of portfolio
-
State Street Corp Boston, MA4.01MShares$222 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.28MShares$182 Million0.13% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.32B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....